Abstract: FR-PO422

Indian Chronic Kidney Disease (ICKD) Study: A Prospective Cohort Study of CKD Patients in India

Session Information

Category: Chronic Kidney Disease (Non-Dialysis)

  • 301 CKD: Risk Factors for Incidence and Progression


  • Yadav, Ashok Kumar, PGIMER, Chandigarh, India
  • Varughese, Santosh, CMC, Vellore, India
  • Singh, Shivendra, Banaras Hindu University, Varanasi, India
  • Jha, Vivekanand, George Institute for Global Health, New Delhi, India
  • Kumar, Vivek, Postgraduate Institute of Medical Education and Research, Chandigarh, India
  • Bhansali, Shobhit, PGIMER, Chandigarh, India
  • Modi, Gopesh K., Samarpan kidney Institute & Research Ctr., Bhopal, MadhyaPradesh, India
  • Gang, Sishir D., MULJIBHAI PATEL UROLOGICAL HOSPITAL, Nadiad, Gujarat, India
  • Prakash, Jai, Banaras Hindu University, Varanasi, India
  • Sircar, Dipankar, IPGMER,SSKM HOSPITAL, KOLKATA, India
  • Parameswaran, Sreejith, JIPMER, Ponidcherry, India
  • Prasad, Narayan, SGPGIMS CAMPUS, Lucknow, India

The Indian Chronic Kidney Disease (ICKD) study (https://ickd.georgeinstitute.org.in/) is a multi-centric, prospective, observational cohort study of early stage CKD patients in India which will ascertain rate and factors influencing progression of CKD in India.


Adult subjects with mild to moderate CKD [estimated glomerular filtration rate (eGFR) 30-60 ml/min/1.73m2 or eGFR >60 ml/min/1.73m2 with proteinuria/albuminuria] are eligible for enrolment. Approximately 5000 subjects would be enrolled over 18 months. Time to 50% decline in eGFR, need of renal replacement therapy, CVD event or death are primary end points. A central bio-repository with serial biological samples is coupled with this cohort. Socio-economic aspects of treatment will also be studied.


A total of 1567 subjects have been enrolled in the ICKD cohort till May 2017. The cause of CKD could not be ascertained in 25% of subjects. Chronic glomerulonephritis, diabetic kidney disease and chronic interstitial nephritis are causes for CKD in 16.5%, 18% and 17% of subjects, respectively. Tables 1 shows selective demographic characteristics of enrolled subjects. Majority are males belonging to rural areas with occupation exposure to sand, dust, chemicals or animals etc. 24% subjects had used alternative drugs and 10% had history suggestive of AKI in the past.


This is the first and most comprehensive description of an early stage CKD cohort from a developing country.


  • Government Support - Non-U.S.